Adrianne Wallace-Povirk , PhD

Research Associate, Henry Ford Health System

Location: HENRY FORD HOSPITAL - DETROIT
2799 W GRAND BLVD

Department: Pharmacology & Toxicology

Education

PhD, Cancer Biology, Dr. Larry Matherly's Laboratory, Oncology, Wayne State University, 2021
Bachelor of Science, Biology, Biology, Oakland University, 2013

Employment

Postdoctoral Fellow, Henry Ford Health System, Detroit, 2025 - Present
Postdoctoral Fellow, Fred Hutchinson Cancer Center, Seattle, 2021 - 2025
Research Assistant, Dr. Larry Matherly's Laboratory, Wayne State University, Detroit, 2013 - 2016

Publications

Supplemental Figure S1 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Figure S2 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Figure S3 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Figure S4 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Figure S5 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Figure S6 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Table S1 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Table S2 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Table S3 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Supplemental Table S4 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer (2026)

Fundings

Exploring the molecular mechanisms controlling CDK7i sensitivity in pancreas cancer

Targeting Mitochondrial One-Carbon Metabolism in Epithelial Ovarian Cancer